Experimental study of antisense oligodeoxynucleotide targeting matrix metalloproteinase-9 gene for human lung adenocarcinoma xenograft in nude mice

Bi-xiu HE,Cheng-ping HU,Shuo LIANG

DOI: https://doi.org/10.3760/cma.j.issn.1673-436X.2008.10.005

2008-01-01

Abstract:Objective To explore the feasibility of antisense oligodeoxynucleotide(ASODN)targeting matrix metalloproteinase-9(MMP-9)gene for human lung adenocarcinoma xenograft in nude mice.Methods Cell lines A549 were cultured routinely with RPMI 1640 medium.A549 cells were subcutaneously implanted in nude mice to establish xenograft animal models.After MMP-9 ASODN mediated by cytofectin was directly imected into xenograft in 5 places,the volumes and mass of tumor mass were detected,respectively,and then tumor growth inhibitory rate and tumor growth index were calculated.Results Tumor growth index in MMP-9 ASODN/Liposome(Lip)group was 3.20±0.14,which was less than other three groups(5.93±0.20,5.87±0.02 and 6.40±0.33)(P＜0.0t).The tumor mass in MMP-9 ASODN/Lip group was(1.25±0.03)g,which was less than other three groups[(2.15±0.07)g,(2.31±0.04)g and (2.43±0.04)g](P＜0.01).The inhibition rate of tumor in MMP-9 ASODN/Lip group was(33.41±1.18)%.There were no obvious tissue damages in heart,liver and kidney.Conclusions MMP-9 ASODN mediated by cytofectin can inhibit the tumor growth by direct intratumoral injection and no adverse effect.ASODN targeting MMP-9 gene can be a supportive therapy method of lung cancer.